Ascendiant Capital Markets Issues Pessimistic Forecast for ENDRA Life Sciences (NASDAQ:NDRA) Stock Price

ENDRA Life Sciences (NASDAQ:NDRA) had its price target lowered by equities researchers at Ascendiant Capital Markets from $38.00 to $30.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Ascendiant Capital Markets’ target price would indicate a potential upside of 417.24% from the stock’s current price.

Several other research firms have also weighed in on NDRA. Wall Street Zen upgraded shares of ENDRA Life Sciences to a “sell” rating in a report on Saturday, November 22nd. Weiss Ratings restated a “sell (e+)” rating on shares of ENDRA Life Sciences in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, ENDRA Life Sciences has an average rating of “Hold” and an average price target of $30.00.

ENDRA Life Sciences Trading Up 5.8%

NASDAQ:NDRA opened at $5.80 on Monday. ENDRA Life Sciences has a 1-year low of $2.90 and a 1-year high of $11.96. The firm has a market capitalization of $4.35 million, a price-to-earnings ratio of -0.22 and a beta of -0.33. The business’s 50-day moving average price is $5.88 and its two-hundred day moving average price is $5.10.

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earnings results on Friday, November 14th. The company reported ($1.75) EPS for the quarter, beating analysts’ consensus estimates of ($1.95) by $0.20. Sell-side analysts predict that ENDRA Life Sciences will post -47.46 earnings per share for the current year.

ENDRA Life Sciences Company Profile

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.